- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sarepta Therapeutics Inc (SRPT)Assess today's live Sarepta Therapeutics Inc (SRPT) share price, performance and insights using our live NASDAQ: SRPT stock exchange data.
Analyse the historical data and Sarepta Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Sarepta share price buy/sell indicators using real-time data (or discuss the Sarepta (SRPT) stock price today with other investors in the Sarepta NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SRPT share price (ISIN: US8036071004) to enhance your trading decisions with our free investment tools and resources.
What Is the Sarepta Therapeutics Inc Share Price Today?
The Sarepta share price today is 127.99.
What Is the Stock Symbol for Sarepta Therapeutics Inc
The stock symbol (or 'ticker') for Sarepta Therapeutics Inc is "SRPT."
What Stock Exchange Does Sarepta Therapeutics Inc Trade On?
Sarepta Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Sarepta Therapeutics Inc a Good Stock to Buy?
Determining whether Sarepta Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Sarepta Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Sarepta share price buy/sell indicators using real-time data (or discuss the Sarepta (SRPT) stock price today with other investors in the Sarepta NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SRPT share price (ISIN: US8036071004) to enhance your trading decisions with our free investment tools and resources.
What Is the Sarepta Therapeutics Inc Share Price Today?
The Sarepta share price today is 127.99.
What Is the Stock Symbol for Sarepta Therapeutics Inc
The stock symbol (or 'ticker') for Sarepta Therapeutics Inc is "SRPT."
What Stock Exchange Does Sarepta Therapeutics Inc Trade On?
Sarepta Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Sarepta Therapeutics Inc a Good Stock to Buy?
Determining whether Sarepta Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
127.99
+1.71(+1.35%)
Closed
After Hours
129.32+1.33(+1.04%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
125.52
129.06
52 wk Range
85.61
173.25
SRPT Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
125.52129.06
52 wk Range
85.61173.25
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockSRPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
183.60
Upside
+43.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
- Sarepta receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sarepta receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Sarepta receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sarepta receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Sarepta Company Profile
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children’s Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Sarepta Therapeutics Inc SWOT Analysis
DMD Market Leade | Sarepta Therapeutics dominates the Duchenne muscular dystrophy market with Elevidys, its groundbreaking gene therapy now approved for patients 6 and olde |
Financial Momentum | Q3 2024 revenue surpassed expectations at $430 million, driven by Elevidys' success. Analysts project peak U.S. sales of $2.7 billion for the therapy |
Strategic Pivot | Explore Sarepta's shift towards promising Limb-Girdle gene therapies, with regulatory filings expected in 2025, following PPMO franchise discontinuation |
Analyst Optimism | Discover why analysts maintain bullish outlooks, with price targets ranging from $167 to $209, reflecting confidence in Sarepta's growth potential |
SRPT Full Pro Research
Institutional-Grade Stock Analysis
Understand how SRPT earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Compare SRPT to Peers and Sector
Metrics to compare | SRPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 100.3x | −5.7x | −0.7x | |
PEG Ratio | 0.87 | −0.14 | 0.00 | |
Price/Book | 10.0x | 2.1x | 2.6x | |
Price / LTM Sales | 7.5x | 19.7x | 3.2x | |
Upside (Analyst Target) | 51.8% | 44.6% | 44.1% | |
Fair Value Upside | Unlock | 8.4% | 8.2% | Unlock |
Analysts' Recommendations
22 Buy
0 Hold
1 Sell
Ratings:
22 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 183.60
(+43.45% Upside)
People Also Watch
FAQ
What Is the Sarepta (SRPT) Stock Price Today?
The Sarepta stock price today is 127.99
What Stock Exchange Does Sarepta Trade On?
Sarepta is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Sarepta?
The stock symbol for Sarepta is "SRPT."
What Is the Sarepta Market Cap?
As of today, Sarepta market cap is 12.28B.
What is Sarepta Earnings Per Share?
The Sarepta EPS is 1.26.
What Is the Next Sarepta Earnings Date?
Sarepta will release its next earnings report on 04 Mar 2025.
From a Technical Analysis Perspective, Is SRPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.